Literature DB >> 16224024

Sequence variants in SLITRK1 are associated with Tourette's syndrome.

Jesse F Abelson1, Kenneth Y Kwan, Brian J O'Roak, Danielle Y Baek, Althea A Stillman, Thomas M Morgan, Carol A Mathews, David L Pauls, Mladen-Roko Rasin, Murat Gunel, Nicole R Davis, A Gulhan Ercan-Sencicek, Danielle H Guez, John A Spertus, James F Leckman, Leon S Dure, Roger Kurlan, Harvey S Singer, Donald L Gilbert, Anita Farhi, Angeliki Louvi, Richard P Lifton, Nenad Sestan, Matthew W State.   

Abstract

Tourette's syndrome (TS) is a genetically influenced developmental neuropsychiatric disorder characterized by chronic vocal and motor tics. We studied Slit and Trk-like 1 (SLITRK1) as a candidate gene on chromosome 13q31.1 because of its proximity to a de novo chromosomal inversion in a child with TS. Among 174 unrelated probands, we identified a frameshift mutation and two independent occurrences of the identical variant in the binding site for microRNA hsa-miR-189. These variants were absent from 3600 control chromosomes. SLITRK1 mRNA and hsa-miR-189 showed an overlapping expression pattern in brain regions previously implicated in TS. Wild-type SLITRK1, but not the frameshift mutant, enhanced dendritic growth in primary neuronal cultures. Collectively, these findings support the association of rare SLITRK1 sequence variants with TS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224024     DOI: 10.1126/science.1116502

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  342 in total

1.  Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome.

Authors:  Hao Wu; Jifang Tao; Pauline J Chen; Atif Shahab; Weihong Ge; Ronald P Hart; Xiaoan Ruan; Yijun Ruan; Yi E Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.

Authors:  Thomas V Fernandez; Stephan J Sanders; Ilana R Yurkiewicz; A Gulhan Ercan-Sencicek; Young-Shin Kim; Daniel O Fishman; Melanie J Raubeson; Youeun Song; Katsuhito Yasuno; Winson S C Ho; Kaya Bilguvar; Joseph Glessner; Su Hee Chu; James F Leckman; Robert A King; Donald L Gilbert; Gary A Heiman; Jay A Tischfield; Pieter J Hoekstra; Bernie Devlin; Hakon Hakonarson; Shrikant M Mane; Murat Günel; Matthew W State
Journal:  Biol Psychiatry       Date:  2011-12-14       Impact factor: 13.382

Review 3.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 4.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 5.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

6.  Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3'UTR.

Authors:  Chang Sun; Catherine Southard; Olufunmilayo I Olopade; Anna Di Rienzo
Journal:  Gene       Date:  2011-04-13       Impact factor: 3.688

Review 7.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

Review 8.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 9.  Advances in understanding and treatment of Tourette syndrome.

Authors:  Kevin St P McNaught; Jonathan W Mink
Journal:  Nat Rev Neurol       Date:  2011-11-08       Impact factor: 42.937

10.  The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.

Authors:  Kevin P Jensen; Henry R Kranzler; Murray B Stein; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-16       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.